GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 72 filers reported holding GAMIDA CELL LTD in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,462,204 | -6.1% | 1,419,616 | +98.7% | 0.01% | +22.2% |
Q2 2022 | $1,558,000 | -56.0% | 714,534 | -16.3% | 0.01% | -40.0% |
Q1 2022 | $3,542,000 | +85.6% | 853,501 | +13.6% | 0.02% | +150.0% |
Q4 2021 | $1,908,000 | -22.0% | 751,069 | +20.4% | 0.01% | 0.0% |
Q3 2021 | $2,445,000 | -44.6% | 623,674 | -9.5% | 0.01% | -25.0% |
Q2 2021 | $4,417,000 | -18.6% | 689,129 | +2.8% | 0.01% | -27.3% |
Q1 2021 | $5,423,000 | +100.7% | 670,324 | +108.2% | 0.01% | +57.1% |
Q4 2020 | $2,702,000 | +249.1% | 322,026 | +72.7% | 0.01% | +40.0% |
Q3 2020 | $774,000 | – | 186,415 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
Platform Technology Partners | 45,375 | $291,000 | 0.12% |
PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |